AKBA (STOCKS)
Akebia Therapeutics, Inc.
$0.926800
+0.002300 (+0.25%)
Prev close: $0.924500
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- John P. Butler
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $252.02M
- Employees
- 181
- P/E (TTM)
- -11.98
- P/B (TTM)
- 9.05
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $232.40M |
| Benefits Costs and Expenses | $251.17M |
| Cost Of Revenue | $44.13M |
| Costs And Expenses | $251.17M |
| Gross Profit | $188.28M |
| Operating Expenses | $182.99M |
| Selling, General, and Administrative Expenses | $112.17M |
| Research and Development | $67.41M |
| Other Operating Expenses | $3.40M |
| Operating Income/Loss | $5.29M |
| Income/Loss From Continuing Operations After Tax | -$20.51M |
| Income/Loss From Continuing Operations Before Tax | -$18.76M |
| Income Tax Expense/Benefit | $1.75M |
| Net Income/Loss | -$20.51M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$20.51M |
| Net Income/Loss Available To Common Stockholders, Basic | -$20.51M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.08 |
| Diluted Earnings Per Share | -$0.08 |
| Basic Average Shares | 797,165,967 |
| Diluted Average Shares | 807,000,336 |
| Assets | $362.52M |
| Current Assets | $243.48M |
| Inventory | $13.00M |
| Other Current Assets | $230.49M |
| Noncurrent Assets | $119.04M |
| Fixed Assets | $956.00K |
| Other Non-current Assets | $118.08M |
| Liabilities | $335.15M |
| Current Liabilities | $173.88M |
| Accounts Payable | $8.39M |
| Wages | $8.32M |
| Other Current Liabilities | $157.18M |
| Noncurrent Liabilities | $161.26M |
| Long-term Debt | $48.89M |
| Other Non-current Liabilities | $112.37M |
| Equity | $27.38M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $27.38M |
| Liabilities And Equity | $362.52M |
| Net Cash Flow From Operating Activities | $60.37M |
| Net Cash Flow From Operating Activities, Continuing | $60.37M |
| Net Cash Flow From Investing Activities | -$8.14M |
| Net Cash Flow From Investing Activities, Continuing | -$8.14M |
| Net Cash Flow From Financing Activities | -$2.94M |
| Net Cash Flow From Financing Activities, Continuing | -$2.94M |
| Net Cash Flow | $49.29M |
| Net Cash Flow, Continuing | $49.29M |
| Comprehensive Income/Loss | -$20.51M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$20.51M |
| Other Comprehensive Income/Loss | -$20.76M |